STAT3 and Its Targeting Inhibitors in Oral Squamous Cell Carcinoma

Oral squamous cell carcinoma (OSCC) usually originates from the precancerous lesions of oral mucosa and accounts for approximately 90% of oral cancers. Current therapeutic approaches do not yet meet the needs of patients, and the 5-year survival rate of patients with OSCC is only 50%. Recent studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Mingjing, Li, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563058/
https://www.ncbi.nlm.nih.gov/pubmed/36231093
http://dx.doi.org/10.3390/cells11193131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563058/
https://www.ncbi.nlm.nih.gov/pubmed/36231093
http://dx.doi.org/10.3390/cells11193131

Ejemplares similares